|
|
| Maladies Infectieuses > Etude de marché sectorielle |
| Chinese Markets for HIV Drugs |
|
|
|
|
€ 2 835,00 |
Editeur
: |
Amid Co |
Langue
: |
Anglais |
Date de publication : |
Janvier 2003 |
Taille du document : |
190 |
Autres informations : |
Description , Table des matières |
| |
|
|
|
|
| |
Documents Publics |
1,200,000
documents |
Téléchargement illimités |
|
|
|
Etudes Privées |
50,000 rapports et études |
Paiement à la piéce |
|
|
|
|
| |
|
1.Télécharger nos rapports publics
Accés complet à plus de 1,2 Million de documents publics : études de marché, statistiques sectorielles, fiches pays, monographie d'entreprises, veille concurentielle, rapports annuels...
|
| Nos documents publics sur le même théme (1) |
|
|
|
| 20 pages | Juillet 2004 | Anglais
|
|
|
| Main
focus: |
mail order,mail-order,hiv drug,protease inhibitor,...
|
| Research
focus: |
market size and estimates,market outlook |
| Geographic
focus: |
france |
| |
|
|
|
|
| Autres recherches sur le même thème |
|
|
|
| |
| |
|
| |
|
2.
Rechercher d'autres rapports et études à commander
Rechercher et commander ici parmi 50.000 études de marché publiées par les principaux instituts d'études internationaux
|
| Rapports privés en relation |
|
The Vaccines Market Outlook: Market analysis of future growth and leading players by sector
122 pages | Janvier 2005 |
Business Insights have teamed up with IMS Health to bring you, ‘The Vaccines Market Outlook: Market analysis of future growth and leading players by sector.’ This unique report provides unrivalled ana |
2 443,75 €
|
| |
| |
Stakeholder Insight: Hepatitis in China - Liver Let Die?
310 pages | Décembre 2005 |
IntroductionHepatitis is a major health problem in China, which is home to one third of hepatitis B patients and one quarter of hepatitis C patients globally.
HBV vaccination, together with HBV and |
12 920,00 €
|
| |
| |
Monoclonal Antibody Based Products
489 pages | Octobre 2005 |
This report analyzes the worldwide markets for Monoclonal Antibody Based Products in Millions of US$.
The major product segments analyzed are Therapeutics, and Diagnostics.
The sub product segme |
2 308,00 €
|
| |
| |
Pipeline Insight: Hepatitis C - Small Molecules, Big Revolution
237 pages | Avril 2005 |
IntroductionLess than 50% of chronically infected hepatitis C patients do not benefit from the current standard of care, pegylated interferon plus ribavirin.
In the short-term, the treatment landsc |
9 120,00 €
|
| |
| |
Stakeholder Insight: Hepatitis in China - Liver Let Die?
310 pages | Décembre 2005 |
IntroductionHepatitis is a major health problem in China, which is home to one third of hepatitis B patients and one quarter of hepatitis C patients globally.
HBV vaccination, together with HBV and |
12 920,00 €
|
| |
| |
Commercial Perspectives: HIV - Benchmarking Rapid Antiretroviral Uptake
181 pages | Février 2005 |
IntroductionHistorically, HIV antiretrovirals have differed markedly in their speed of market uptake.
Now, to win market share in an already mature market, newly launched products need not only a s |
9 120,00 €
|
| |
| |
03-054: Immunohistochemistry Market Benchmarking Survey
90 pages | Octobre 2003 |
This report provides an overview of the most commonly used methods and products for tissue/sample preparation and antigen detection to help suppliers understand researchers’ experiences, preferences a |
680,00 €
|
| |
| |
Recommendations for Diagnostic Testing for Hepatitis B
1 pages | Janvier 2006 |
This Database Table is a one-page table of hard-to-find numerical information.
The Database Table is derived from a proprietary source and is meant to simply provide a high-level overview of specif |
80,00 €
|
| |
| |
Stakeholder Insight: Psoriasis - Biologics Impact Treatment Regimes Across the Globe
203 pages | Février 2005 |
IntroductionPsoriasis is a non-life threatening but highly debilitating disease that currently has no cure.
Traditional treatments often either lack efficacy or are effective but have very poor sid |
12 160,00 €
|
| |
| |
Lower Detection Limits of HBV DNA Assays
1 pages | Janvier 2006 |
This Database Table is a one-page table of hard-to-find numerical information.
The Database Table is derived from a proprietary source and is meant to simply provide a high-level overview of specif |
80,00 €
|
| |
| |
|
| |
| Autres secteurs en relation |
|
|
|
| |
|
| |
| |
| Présentation de l'étude de marché - Description & Table des matières |
|
| Chinese Markets for HIV Drugs |
|
|
China's demand for HIV drugs has grown at a fast pace in the past decade. In the next five years, both production and demand will continue to grow. This new study examines China's economic trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. Historical data (1991, 1996 and 2001) and long-term forecasts throught 2006 and 2011 are presented. Major producers in China are profiled.
|
|
TABLE OF CONTENTS
I. INTRODUCTION
Report Scope and Methodology
Executive Summary
II. BUSINESS ENVIRONMENT
Economic Outlook
Key Economic Indicators
Industrial Output
Population and Labor
Foreign Investment
Foreign Trade
Financial and Tax Regulations
Banking System and Regulations
Foreign Exchange
Taxes, Tariff and Custom Duties
III. HIV TREATMENT DRUGS INDUSTRY ASSESSMENTS
Overview of HIV/AIDS
Transmission of HIV
HIV Treatment Drugs Industry Structure
Treatment Methods of HIV Carriers
China’ Market Size
Major Producer Facility Locations and Output
Market Share of Key Producers
Main Foreign HIV Treatment Drugs Producers
Labor Costs
Potential Entrants
Major Distributors
Major Foreign Investments
China’ Technology Development
Technology Development in Developed Countries
IV. HIV TREATMENT DRUGS OUTPUTS AND FORECASTS
Overview
Western HIV Treatment Drugs Production and Demand
Western HIV Treatment Drugs Introduction
Major Producers
Foreign Trade
Total Output and Demand
Western HIV Treatment Drugs Output and Demand
Nucleoside Reverse Transcriptase Inhibitors
Non-Nucleoside Reverse Transcriptase Inhibitors
Proteinase Inhibitors
Pricing Trends
Regional Characteristics of Western HIV Treatment Drugs Output and Demand
Chinese Traditional HIV Treatment Drugs Production and Demand
Chinese Traditional HIV Treatment Drugs Introduction
Major Producers
Foreign Trade
Total Output and Demand
Pricing Trends
Regional Characteristics of Chinese Traditional HIV Treatment Drugs Output and Demand
V. HIV TREATMENT DRUGS MARKET OUTLOOKS
HIV Treatment Drugs Markets Outlook Overview
Government HIV Treatment Drugs Regulations
Health Care Insurance Industry Overview
China’s Health Care and HIV Carriers Treatment Overview
Treatment revenues
Hospitals
Physicians
China’s Population Overview
Population by Region
Northeast
North
Southeast
Central South
Southwest
Northwest
Population by Age Group
China’s HIV Carriers Overview
China’s HIV Carriers by Region
Northeast
North
Southeast
Central South
Southwest
Northwest
China’s HIV Carriers by Age Group
HIV Carriers Spending Trends
VI. MARKETING STRATEGIES
Distribution System in China
China's Distribution System
The Pharmaceuticals Distribution Channels
Transportation and Freight Infrastructure
Communications
Market Entry Channels
Exporting to China
Export Market Overview
Chinese Trading Practice
Trading Companies
Import Restrictions in China
Technology Licensing
Technology Licensing Overview
Intellectual Property Protection
Joint Venture
Joint Venture Overview
Advantages and Disadvantages
Wholly Owned Enterprises
Foreign Wholly Owned Enterprises Overview
Advantages and Disadvantages
Other Market Entry Channels
Setting up Sales Offices
Selling to China Through Attending Trade Fairs
Contacting Chinese Companies
Advertising
Market Entry Strategies
Understanding Differences
Business Practice Differences
Knowledge of Regulations and Restrictions
Dealing with Governments
VII. HIV TREATMENT DRUGS PRODUCERS PROFILES AND DIRECTORY
Western HIV Treatment Drugs Producers Profiles
Chinese Traditional HIV Treatment Drugs Producers Profiles
HIV Carriers Treatment Hospital Profiles
Distributors
Trading Companies
Research Institutions and Associations
LIST OF TABLES
I. INTRODUCTION
Report Scope and Methodology
Executive Summary
II. BUSINESS ENVIRONMENT
Key Economic Indicators
Industrial Output
Population and Labor Force Trends
Foreign Investment and Loans
Foreign Trade
Key Commodity Exports from China
China’s Exports to its Leading Trade Partners
Key Commodity Imports into China
China’s Imports from Its Leading Trade Partners
III. HIV TREATMENT DRUGS INDUSTRY ASSESSMENTS
Major Producer Facility Locations and Output
Market Share of Key Producers
Major Distributors
Major Foreign Investments
IV. HIV TREATMENT DRUGS OUTPUTS AND FORECASTS
Total HIV Treatment Drugs Output and Demand
Western HIV Treatment Drugs Production and Demand
Major Producers
Foreign Trade
Total Output and Demand
Western HIV Treatment Drugs Production and Demand
Nucleoside Reverse Transcriptase Inhibitors
Non-Nucleoside Reverse Transcriptase Inhibitors
Western HIV Treatment Drugs Output and Demand by Region
Chinese Traditional HIV Treatment Drugs Production and Demand
Major Producers
Foreign Trade
Total Output and Demand
Chinese Traditional HIV Treatment Drugs Output and Demand by Region
V. HIV TREATMENT DRUGS MARKET OUTLOOKS
China’s Health Care and Obesity Treatment Overview
Treatment revenues
Hospitals
Physicians
China’s Population Overview
Population by Region
Northeast
North
Southeast
Central South
Southwest
Northwest
Population by Age Group
China’s HIV Carriers Overview
China’s HIV Carriers by Region
Northeast
North
Southeast
Central South
Southwest
Northwest
China’s HIV Carriers by Age Group
HIV Carriers Spending Trends
LIST OF CHARTS
HIV Treatment Drugs Production and Demand Summary
China's GDP and Industrial Output
Population Trends
Industrial Output by Ownership
Foreign Investments and Loans
China’s Imports and Exports
Key Commodity Exports from China
Key Commodity Imports into China
HIV Treatment Drugs Output and Demand
HIV Treatment Drugs Production in 2001
HIV Treatment Drugs Demand by Market in 2006
|
|
|
PPLSEN
|
|
|
|
|
